At diagnosis, she was not expected to live for more than a few years, according to a White House statement. It took Crowley’s father, John, to launch the New Jersey biotechnology company Amicus Therapeutics to identify a drug treatment that would save her life, Trump said. " But our slow and burdensome approval process at the Food and Drug Administration keeps too many advances, like the one that saved Megan’s life, from reaching those in need," Trump said in his speech. 